News Daily News Trials of New Cancer Drugs Failing to Address Potential CV Risks Todd Neale February 10, 2020
News Daily News Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication Michael O'Riordan January 17, 2020
News Daily News No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry Todd Neale January 15, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Daily News Diabetes Does Not Appear to Hinder FFR Insights for CAD Caitlin E. Cox January 09, 2020
Presentation Cardiovascular Interventions 2019 PCSK9 Inhibitors for the Interventionalist: Which Patients Do We Choose and How Do We Use? Presenter: Matthew J. Budoff November 01, 2019